On February


 


Gail Cawkwell will serve as acting Chief Medical Officer pending
appointment of a permanent replacement.



 


 



 


 



 


 


SIGNATURES


 


Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 


 




 


INTERCEPT PHARMACEUTICALS, INC.



 


 


 



 


 


 



 


By:


/s/ Jerome Durso



 


 


Name: Jerome Durso



 


 


Title:   President and Chief Executiv e Officer



 


 


Date: February 22, 2021


 


 




 



 






makes a similar move, sign up!

Other recent filings from the company include the following:

Intercept Pharmaceuticals's Chief Qual. Officer & SVP Ops. just disposed of 2,455 shares - Jan. 13, 2022
Departure of Directors or Certain - Jan. 10, 2022
Statement of changes in beneficial ownership of securities - Jan. 4, 2022
SVP of Intercept Pharmaceuticals just disposed of 2,455 shares - Jan. 4, 2022
Intercept Pharmaceuticals's Chief Human Resources Officer just disposed of 1,712 shares - Jan. 4, 2022

Auto Refresh

Feedback